David J. Taber

4.2k total citations
207 papers, 3.0k citations indexed

About

David J. Taber is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David J. Taber has authored 207 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Transplantation, 80 papers in Surgery and 56 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David J. Taber's work include Renal Transplantation Outcomes and Treatments (129 papers), Organ Transplantation Techniques and Outcomes (54 papers) and Pharmacological Effects and Toxicity Studies (32 papers). David J. Taber is often cited by papers focused on Renal Transplantation Outcomes and Treatments (129 papers), Organ Transplantation Techniques and Outcomes (54 papers) and Pharmacological Effects and Toxicity Studies (32 papers). David J. Taber collaborates with scholars based in United States, United Kingdom and Canada. David J. Taber's co-authors include Prabhakar K. Baliga, John W. McGillicuddy, Kenneth D. Chavin, Nicole A. Pilch, Leonard E. Egede, Frank A. Treiber, Titte R. Srinivas, Mulugeta Gebregziabher, James N. Fleming and Charles F. Bratton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Annals of Surgery.

In The Last Decade

David J. Taber

199 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Taber United States	29	1.4k	953	670	418	380	207	3.0k
Thomas E. Burroughs United States	36	919 0.6×	721 0.8×	805 1.2×	292 0.7×	495 1.3×	86	3.7k
Prabhakar K. Baliga United States	36	1.7k 1.2×	1.6k 1.7×	1.4k 2.0×	271 0.6×	387 1.0×	172	3.9k
John W. McGillicuddy United States	24	732 0.5×	528 0.6×	325 0.5×	204 0.5×	348 0.9×	88	1.9k
Rahul M. Jindal United States	34	1.7k 1.2×	1.5k 1.6×	1.0k 1.5×	365 0.9×	170 0.4×	196	4.2k
Cécile Couchoud France	34	693 0.5×	378 0.4×	719 1.1×	232 0.6×	401 1.1×	230	3.6k
Luc Frimat France	31	519 0.4×	727 0.8×	439 0.7×	214 0.5×	180 0.5×	181	3.3k
Peter P. Reese United States	49	2.9k 2.0×	2.6k 2.7×	2.6k 3.9×	299 0.7×	334 0.9×	243	7.0k
Daniela P. Ladner United States	35	829 0.6×	1.7k 1.8×	1.1k 1.6×	91 0.2×	397 1.0×	162	4.0k
Matthew Jose Australia	27	358 0.2×	370 0.4×	345 0.5×	174 0.4×	274 0.7×	142	2.4k
Diane L. Manninen United States	18	492 0.3×	907 1.0×	665 1.0×	131 0.3×	285 0.8×	32	3.3k

Countries citing papers authored by David J. Taber

Since Specialization

Citations

This map shows the geographic impact of David J. Taber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Taber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Taber more than expected).

Fields of papers citing papers by David J. Taber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Taber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Taber. The network helps show where David J. Taber may publish in the future.

Co-authorship network of co-authors of David J. Taber

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Taber. A scholar is included among the top collaborators of David J. Taber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Taber. David J. Taber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bromberg, Jonathan S., Daniel C. Brennan, David J. Taber, et al.. (2025). Donor-derived cell-free DNA significantly improves rejection yield in kidney transplant biopsies. American Journal of Transplantation. 25(12). 2529–2542.

Taber, David J., Elisa J. Gordon, Larissa Myaskovsky, et al.. (2025). Therapeutic needs in solid organ transplant recipients: The American Society of Transplantation patient survey. American Journal of Transplantation. 25(12). 2565–2577. 1 indexed citations

Soliman, Karim, et al.. (2024). Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation. Transplant Infectious Disease. 26(5). e14318–e14318. 3 indexed citations

Taber, David J., et al.. (2023). Results of a multicenter cluster-randomized controlled clinical trial testing the effectiveness of a bioinformatics-enabled pharmacist intervention in transplant recipients. American Journal of Transplantation. 23(12). 1939–1948. 3 indexed citations

Cohen, Elizabeth, et al.. (2023). The measure of impact: Proposal of quality metrics for solid organ transplant pharmacy practice. American Journal of Transplantation. 24(2). 164–176.

Taber, David J., et al.. (2023). A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant Recipients. Progress in Transplantation. 33(2). 121–129. 2 indexed citations

Cina, Robert A., Ralph Ward, William T. Basco, et al.. (2022). Incidence and patterns of persistent opioid use in children following appendectomy. Journal of Pediatric Surgery. 57(12). 912–919. 5 indexed citations

Taber, David J., Elisa J. Gordon, Michelle T. Jesse, et al.. (2022). A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs. Clinical Transplantation. 37(3). e14876–e14876. 3 indexed citations

Taber, David J., et al.. (2021). Transplant clinical pharmacy services improve cardiovascular risk factor management and control in Veteran organ transplant recipients. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(3). 280–287. 1 indexed citations

10.

Taber, David J., et al.. (2021). Challenges for expansion of thoracic transplant clinical pharmacy in a developing country: comparison with U.S. accredited centres and call for action. Journal of Clinical Pharmacy and Therapeutics. 47(5). 588–591. 1 indexed citations

11.

Guo, Kexin, Raymond L. Heilman, Emilio D. Poggio, et al.. (2021). Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 16(10). 1539–1551. 48 indexed citations

12.

Fleming, James N., et al.. (2021). Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy. 78(14). 1287–1293. 21 indexed citations

13.

Taber, David J., et al.. (2021). The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. The American Journal of Surgery. 223(4). 812–816. 3 indexed citations

14.

Ward, Ralph, Erin R. Weeda, David J. Taber, R. Neal Axon, & Mulugeta Gebregziabher. (2021). Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data. Health Services and Outcomes Research Methodology. 22(2). 275–295. 1 indexed citations

15.

Weeda, Erin R., Kinfe G. Bishu, Ralph Ward, et al.. (2020). Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovascular Disorders. 20(1). 449–449. 6 indexed citations

16.

McGillicuddy, John W., Jessica Chandler, Luke Sox, & David J. Taber. (2020). Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. Annals of Pharmacotherapy. 54(12). 1185–1193. 37 indexed citations

17.

McGillicuddy, John W., et al.. (2020). A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. American Journal of Transplantation. 20(8). 1969–1983. 60 indexed citations

18.

McGillicuddy, John W., et al.. (2019). Long‐standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clinical Transplantation. 33(10). e13695–e13695. 2 indexed citations

19.

Hall, Casey, et al.. (2019). Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial. JMIR Research Protocols. 8(10). e13821–e13821. 4 indexed citations

20.

Fleming, James N., Frank A. Treiber, John W. McGillicuddy, Mulugeta Gebregziabher, & David J. Taber. (2018). Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR Research Protocols. 7(3). e59–e59. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact